A Phase II study of vinorelbine, a new derivative of vinca alkaloid, for previously untreated advanced non-small cell lung cancer
- 1 December 1994
- journal article
- Published by Elsevier in Lung Cancer
- Vol. 11 (5-6) , 385-391
- https://doi.org/10.1016/0169-5002(94)92167-9
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patients.Journal of Clinical Oncology, 1994
- Vinorelbine versus vinorelbine plus cisplatin in advanced non-small cell lung cancer: A randomized trialAnnals of Oncology, 1994
- The Current and Future Place of Vinorelbine in Cancer TherapyDrugs, 1992
- A Phase II Study of Navelbine (Vinorelbine) in the Treatment of Non-Small-Cell Lung CancerAmerican Journal of Clinical Oncology, 1991
- Thoracic Radiotherapy Does Not Prolong Survival in Patients with Locally Advanced, Unresectable Non-Small Cell Lung CancerAnnals of Internal Medicine, 1990
- Vinca alkaloids in the treatment of non-small cell lung cancerCancer Treatment Reviews, 1987
- Random prospective study of vindesine versus vindesine plus high-dose cisplatin versus vindesine plus cisplatin plus mitomycin C in advanced non-small-cell lung cancer.Journal of Clinical Oncology, 1986
- New agents in non-small cell lung cancerCancer Treatment Reviews, 1984